Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Tracy Oeller

Physician Assistant Fort Worth, TX Physician Assistant

NPI 1053490425 CMS profile 10440156

6100 Lake Worth Blvd, Fort Worth, TX 76135

Open in the dashboard

General payments

$8,475

433 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tracy Oeller of Fort Worth, TX is reported in the CMS Open Payments database as having received $8,475 across 433 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,678 98
2024 General $1,798 97
2023 General $1,550 95
2022 General $2,356 72
2021 General $1,092 71

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tracy Oeller
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Tracy Oeller were reported at $1,678. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Tracy Oeller Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,092 $132 $37–$438 $132
2022 $2,356 $155 $48–$522 $149
2023 $1,550 $167 $52–$557 $160
2024 $1,798 $178 $55–$600 $164
2025 $1,678 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Baxter Healthcare $1,449 10 payments
  2. Novo Nordisk Inc $1,255 98 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $876 52 payments
  4. AbbVie, Inc. $814 53 payments
  5. Lilly USA, LLC $459 30 payments
  6. Astellas Pharma US Inc $413 20 payments
  7. AstraZeneca Pharmaceuticals LP $354 8 payments
  8. Pfizer Inc. $315 18 payments
  9. GlaxoSmithKline, LLC. $294 16 payments
  10. Dexcom, Inc. $281 14 payments
  11. Other $1,965 114 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,965 422 payments
  2. Debt forgiveness $1,449 10 payments
  3. Education $61 1 payment
Products named General payments · program years 2021–2025
  1. Ozempic $974 81 payments
  2. RYBELSUS $946 79 payments
  3. JARDIANCE Diabetes $406 24 payments
  4. JARDIANCE Diabetes $404 25 payments
  5. FARXIGA $327 6 payments
  6. MOUNJARO $326 21 payments
  7. UBRELVY $301 21 payments
  8. VRAYLAR $291 16 payments
  9. AIRSUPRA $286 3 payments
  10. BREZTRI $285 3 payments
  11. Other $5,276 311 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 146 drugs

Part D claims

7,991

Median for Physician Assistant: 241

Drug cost

$597,551

Median for Physician Assistant: $4,110

Branded share of claims

19.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 66 $84,184
Enbrel Mini Etanercept Brand 11 $80,989
Ozempic Semaglutide Brand 72 $80,671
Eliquis Apixaban Brand 53 $50,063
Mounjaro Tirzepatide Brand 33 $47,922
Trelegy Ellipta Fluticasone/Umeclidin/Vilanter Brand 29 $25,512
Trulicity Dulaglutide Brand 15 $20,368
Januvia Sitagliptin Phosphate Brand 19 $19,678
Xarelto Rivaroxaban Brand 15 $18,848
Tresiba Flextouch U-200 Insulin Degludec Brand 11 $15,224

The 10 drugs with the highest cost, of 146 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$41,157

Of which drugs: $3,713

Medicare patients

230

Average age 73

Services billed

984

163 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 41%
Diabetes 37%
Chronic kidney disease 25%
Ischemic heart disease 23%
Depression 22%
COPD 17%
Heart failure 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Vaccine for influenza for injection into muscle 90662 Office 23 23 $1,872

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 35 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $211
  • Lilly USA, LLC $23
$235 66 —
VRAYLAR
  • AbbVie, Inc. $141
$141 — —
RYBELSUS
  • Novo Nordisk Inc $124
$124 — —
Ozempic
  • Novo Nordisk Inc $124
$124 72 —
NURTEC ODT
  • PFIZER INC. $106
$106 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 35 with Patron

Records

433 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record